AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 1-25/53
TARGETING STRATEGY FOR GENE DELIVERY TO CARCINOEMBRYONIC ANTIGEN-PRODUCING CANCER-CELLS BY RETROVIRUS DISPLAYING A SINGLE-CHAIN VARIABLE FRAGMENT ANTIBODY (VOL 9, PG 235, 1998)
Authors: KONISHI H OCHIYA T CHESTER KA BEGENT RHJ MUTO T SUGIMURA T TERADA M
Citation: H. Konishi et al., TARGETING STRATEGY FOR GENE DELIVERY TO CARCINOEMBRYONIC ANTIGEN-PRODUCING CANCER-CELLS BY RETROVIRUS DISPLAYING A SINGLE-CHAIN VARIABLE FRAGMENT ANTIBODY (VOL 9, PG 235, 1998), Human gene therapy, 9(8), 1998, pp. 1257-1257
TARGETING STRATEGY FOR GENE DELIVERY TO CARCINOEMBRYONIC ANTIGEN-PRODUCING CANCER-CELLS BY RETROVIRUS DISPLAYING A SINGLE-CHAIN VARIABLE FRAGMENT ANTIBODY
Authors: KONISHI H OCHIYA T CHESTER KA BEGENT RHJ MUTO T SUGIMURA T TERADA M
Citation: H. Konishi et al., TARGETING STRATEGY FOR GENE DELIVERY TO CARCINOEMBRYONIC ANTIGEN-PRODUCING CANCER-CELLS BY RETROVIRUS DISPLAYING A SINGLE-CHAIN VARIABLE FRAGMENT ANTIBODY, Human gene therapy, 9(2), 1998, pp. 235-248
EXEMPLIFYING GUIDELINES FOR PREPARATION OF RECOMBINANT-DNA PRODUCTS IN PHASE-I TRIALS IN CANCER - PREPARATION OF A GENETICALLY-ENGINEERED ANTI-CEA SINGLE-CHAIN FV ANTIBODY
Authors: MAYER A CHESTER KA BHATIA J PEDLEY RB READ DA BOXER GM BEGENT RHJ
Citation: A. Mayer et al., EXEMPLIFYING GUIDELINES FOR PREPARATION OF RECOMBINANT-DNA PRODUCTS IN PHASE-I TRIALS IN CANCER - PREPARATION OF A GENETICALLY-ENGINEERED ANTI-CEA SINGLE-CHAIN FV ANTIBODY, European journal of cancer, 34(7), 1998, pp. 968-976
AN ANTI-CEA SINGLE-CHAIN FV ANTIBODY FOR RADIOIMMUNOGUIDED SURGERY INCOLORECTAL-CANCER
Authors: MAYER A BOXER GM OMALLEY D TSIOMPANOU E FLYNN AA DAVIDSON BR WINSLET MC LEWIS AAM DHILLON AP HILSON AJW BEGENT RHJ
Citation: A. Mayer et al., AN ANTI-CEA SINGLE-CHAIN FV ANTIBODY FOR RADIOIMMUNOGUIDED SURGERY INCOLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 167-167
ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT)
Authors: BEGENT RHJ NAPIER MP SHARMA SK SPRINGER CJ BAGSHAWE KD GREEN AJ MARTIN J STRIBBLING SM
Citation: Rhj. Begent et al., ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT), Annals of oncology, 9, 1998, pp. 64-64
MANAGEMENT OF RESISTANT GESTATIONAL TROPHOBLASTIC TUMORS
Authors: NEWLANDS ES BOWER M HOLDEN L SHORT D SECKL MJ RUSTIN GJS BEGENT RHJ BAGSHAWE KD
Citation: Es. Newlands et al., MANAGEMENT OF RESISTANT GESTATIONAL TROPHOBLASTIC TUMORS, Journal of reproductive medicine, 43(2), 1998, pp. 111-118
THE MANAGEMENT OF HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS (GTT)
Authors: NEWLANDS ES BOWER M HOLDEN L SHORT D BROCK C RUSTIN GJS BEGENT RHJ BAGSHAWE KD
Citation: Es. Newlands et al., THE MANAGEMENT OF HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS (GTT), International journal of gynaecology and obstetrics, 60, 1998, pp. 65-70
CLEARANCE OF YTTRIUM-90-LABELED ANTITUMOR ANTIBODIES WITH ANTIBODIES RAISED AGAINST THE 12N4 DOTA MACROCYCLE
Authors: CASEY JL KING DJ PEDLEY RB BODEN JA BODEN R CHAPLIN LC DORNING M BEGENT RHJ
Citation: Jl. Casey et al., CLEARANCE OF YTTRIUM-90-LABELED ANTITUMOR ANTIBODIES WITH ANTIBODIES RAISED AGAINST THE 12N4 DOTA MACROCYCLE, British Journal of Cancer, 78(10), 1998, pp. 1307-1312
RADIOIMMUNOGUIDED SURGERY (RIGS) OF COLORECTAL-CANCER WITH SINGLE-CHAIN FV ANTIBODY TO CEA
Authors: BOXER GM MAYER A OMALLEY D TSIOMPANOU E WINSLET MC LEWIS AAM DHILLON AP HILSON AJW BEGENT RHJ
Citation: Gm. Boxer et al., RADIOIMMUNOGUIDED SURGERY (RIGS) OF COLORECTAL-CANCER WITH SINGLE-CHAIN FV ANTIBODY TO CEA, British Journal of Cancer, 78, 1998, pp. 27-27
BIODISTRIBUTION OF ENZYME-ACTIVITY OF A FUSION PROTEIN FOR USE IN ADEPT
Authors: SHARMA SK BHATIA J PEDLEY RB READ DA MICHAEL P BODEN RW CHESTER KA BEGENT RHJ
Citation: Sk. Sharma et al., BIODISTRIBUTION OF ENZYME-ACTIVITY OF A FUSION PROTEIN FOR USE IN ADEPT, British Journal of Cancer, 78, 1998, pp. 48-48
A DOSIMETRY MODEL FOR THE ACCURATE CHARACTERIZATION OF ABSORBED DOSESIN MOUSE ORGANS
Authors: FLYNN AA GREEN AJ BOXER GM PEDLEY RB BEGENT RHJ
Citation: Aa. Flynn et al., A DOSIMETRY MODEL FOR THE ACCURATE CHARACTERIZATION OF ABSORBED DOSESIN MOUSE ORGANS, British Journal of Cancer, 78, 1998, pp. 60-60
PHAGE-DERIVED SINGLE-CHAIN FV ANTIBODY FRAGMENTS TO VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR
Authors: COOKE SP LAWRENCE L BOXER GM CHESTER KA BEGENT RHJ
Citation: Sp. Cooke et al., PHAGE-DERIVED SINGLE-CHAIN FV ANTIBODY FRAGMENTS TO VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR, British Journal of Cancer, 78, 1998, pp. 91-91
ENHANCEMENT OF ADEPT WITH ANTI-VASCULATURE DRUGS IN A XENOGRAFT MODEL
Authors: PEDLEY RB SHARMA SK BODEN R BOXER GM SPRINGER CJ BEGENT RHJ
Citation: Rb. Pedley et al., ENHANCEMENT OF ADEPT WITH ANTI-VASCULATURE DRUGS IN A XENOGRAFT MODEL, British Journal of Cancer, 78, 1998, pp. 106-106
A DISTRIBUTION STUDY AT SUBMILLIMETER RESOLUTION OF A RECOMBINANT MFE-23-CPG(2) FUSION PROTEIN IN A COLORECTAL-CANCER XENOGRAFT MODEL
Authors: BHATIA J PEDLEY RB SHARMA SK BOXER GM READ DA BODEN RW MICHAEL P CHESTER KA BEGENT RHJ
Citation: J. Bhatia et al., A DISTRIBUTION STUDY AT SUBMILLIMETER RESOLUTION OF A RECOMBINANT MFE-23-CPG(2) FUSION PROTEIN IN A COLORECTAL-CANCER XENOGRAFT MODEL, British Journal of Cancer, 78, 1998, pp. 147-147
PHASE-I STUDY OF RADIOIMMUNOGUIDED SURGERY (RIGS) WITH ANTI-CEA SINGLE-CHAIN FV ANTIBODY IN COLORECTAL-CANCER
Authors: MAYER A BOXER G OMALLEY D CHESTER K DAVIDSON B WINSLET MC HILSON AJW BEGENT RHJ
Citation: A. Mayer et al., PHASE-I STUDY OF RADIOIMMUNOGUIDED SURGERY (RIGS) WITH ANTI-CEA SINGLE-CHAIN FV ANTIBODY IN COLORECTAL-CANCER, European journal of cancer, 33, 1997, pp. 724-724
NOVEL ANTIBODY-BASED FUSION PROTEINS IN CANCER-TREATMENT
Authors: BEGENT RHJ CHESTER KA PEDLEY RB SHARMA SJ ROBSON L BHATIA J
Citation: Rhj. Begent et al., NOVEL ANTIBODY-BASED FUSION PROTEINS IN CANCER-TREATMENT, European journal of cancer, 33, 1997, pp. 87-87
TREATMENT OF MEN WITH METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS WITH CYCLICAL POMB ACE CHEMOTHERAPY/
Authors: BOWER M NEWLANDS ES HOLDEN L RUSTIN GJS BEGENT RHJ
Citation: M. Bower et al., TREATMENT OF MEN WITH METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS WITH CYCLICAL POMB ACE CHEMOTHERAPY/, Annals of oncology, 8(5), 1997, pp. 477-483
EMA CO FOR HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS - RESULTS FROM A COHORT OF 272 PATIENTS/
Authors: BOWER M NEWLANDS ES HOLDEN L SHORT D BROCK C RUSTIN GJS BEGENT RHJ BAGSHAWE KD
Citation: M. Bower et al., EMA CO FOR HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS - RESULTS FROM A COHORT OF 272 PATIENTS/, Journal of clinical oncology, 15(7), 1997, pp. 2636-2643
ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY - PHARMACOKINETICS AND PLASMA-LEVELS OF PRODRUG AND DRUG IN A PHASE-I CLINICAL-TRIAL
Authors: MARTIN J STRIBBLING SM POON GK BEGENT RHJ NAPIER M SHARMA SK SPRINGER CJ
Citation: J. Martin et al., ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY - PHARMACOKINETICS AND PLASMA-LEVELS OF PRODRUG AND DRUG IN A PHASE-I CLINICAL-TRIAL, Cancer chemotherapy and pharmacology, 40(3), 1997, pp. 189-201
SINGLE-CHAIN FV ANTIBODIES FOR TARGETING CANCER-THERAPY
Authors: BEGENT RHJ CHESTER KA
Citation: Rhj. Begent et Ka. Chester, SINGLE-CHAIN FV ANTIBODIES FOR TARGETING CANCER-THERAPY, Biochemical Society transactions, 25(2), 1997, pp. 715-717
CLINICAL-EVIDENCE OF EFFICIENT TUMOR TARGETING BASED ON SINGLE-CHAIN FV ANTIBODY SELECTED FROM A COMBINATORIAL LIBRARY
Authors: BEGENT RHJ VERHAAR MJ CHESTER KA CASEY JL GREEN AJ NAPIER MP HOPESTONE LD CUSHEN N KEEP PA JOHNSON CJ HAWKINS RE HILSON AJW ROBSON L
Citation: Rhj. Begent et al., CLINICAL-EVIDENCE OF EFFICIENT TUMOR TARGETING BASED ON SINGLE-CHAIN FV ANTIBODY SELECTED FROM A COMBINATORIAL LIBRARY, Nature medicine, 2(9), 1996, pp. 979-984
PLACENTAL SITE TROPHOBLASTIC TUMOR - MOLECULAR ANALYSIS AND CLINICAL-EXPERIENCE
Authors: BOWER M PARADINAS FJ FISHER RA NICHOLSON SK RUSTIN GJS BEGENT RHJ BAGSHAWE KD NEWLANDS ES
Citation: M. Bower et al., PLACENTAL SITE TROPHOBLASTIC TUMOR - MOLECULAR ANALYSIS AND CLINICAL-EXPERIENCE, Clinical cancer research, 2(5), 1996, pp. 897-902
BIODISTRIBUTION STUDIES
Authors: BEGENT RHJ BAGSHAWE KD
Citation: Rhj. Begent et Kd. Bagshawe, BIODISTRIBUTION STUDIES, Advanced drug delivery reviews, 22(3), 1996, pp. 325-329
FIRST CLINICAL-EXPERIENCE WITH ADEPT
Authors: BAGSHAWE KD BEGENT RHJ
Citation: Kd. Bagshawe et Rhj. Begent, FIRST CLINICAL-EXPERIENCE WITH ADEPT, Advanced drug delivery reviews, 22(3), 1996, pp. 365-367
TC-99M RADIOLABELING USING A PHAGE-DERIVED SINGLE-CHAIN FV WITH A C-TERMINAL CYSTEINE
Authors: VERHAAR MJ KEEP PA HAWKINS RE ROBSON L CASEY JL PEDLEY B BODEN JA BEGENT RHJ CHESTER KA
Citation: Mj. Verhaar et al., TC-99M RADIOLABELING USING A PHAGE-DERIVED SINGLE-CHAIN FV WITH A C-TERMINAL CYSTEINE, The Journal of nuclear medicine, 37(5), 1996, pp. 868-872
Risultati: 1-25 | 26-50 | 51-53